Multiple Sclerosis (MS) is a neuroinflammatory disease that affects myelin. While researchers haven’t been able to identify the cause of MS with certainty, there has been a tremendous amount of progress in research; especially in the development of treatments to prevent exacerbations.
High-quality samples are paramount in developing new treatments for Multiple Sclerosis. HemaCare sources, isolates, and ships human blood components and cells under rigorously controlled protocols to provide the optimum starting material for your research.
Patients diagnosed with Multiple Sclerosis are recruited as volunteer donors for research products. They review and sign an independent biomedical review board (IRB) approved procedure-specific consent form prior to the collection.
Use whole blood unit immediately upon receipt.
Testing: Donors are tested for HBV, HCV, and HIV, unless requested otherwise.